BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19839593)

  • 1. Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
    Larsen CA; Bisson WH; Dashwood RH
    J Med Chem; 2009 Nov; 52(21):6543-5. PubMed ID: 19839593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins.
    Leone M; Zhai D; Sareth S; Kitada S; Reed JC; Pellecchia M
    Cancer Res; 2003 Dec; 63(23):8118-21. PubMed ID: 14678963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide.
    Larsen CA; Dashwood RH
    Biochem Biophys Res Commun; 2009 Nov; 389(3):527-30. PubMed ID: 19744467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.
    Larsen CA; Dashwood RH
    Arch Biochem Biophys; 2010 Sep; 501(1):52-7. PubMed ID: 20361925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
    Shan HM; Shi Y; Quan J
    ChemMedChem; 2015 Jan; 10(1):158-63. PubMed ID: 25196850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL; Cardelli JA
    Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase.
    Wang X; Song KS; Guo QX; Tian WX
    Biochem Pharmacol; 2003 Nov; 66(10):2039-47. PubMed ID: 14599562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical strategy coupled to chemometrics to differentiate Camellia sinensis tea types based on phenolic composition, alkaloids, and amino acids.
    Jiang H; Zhang M; Wang D; Yu F; Zhang N; Song C; Granato D
    J Food Sci; 2020 Oct; 85(10):3253-3263. PubMed ID: 32856300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
    Bode AM; Dong Z
    Cancer Prev Res (Phila); 2009 Jun; 2(6):514-7. PubMed ID: 19470792
    [No Abstract]   [Full Text] [Related]  

  • 10. Black tea polyphenols-mediated in vivo cellular responses during carcinogenesis.
    Kumar G; Pillare SP; Maru GB
    Mini Rev Med Chem; 2010 Jun; 10(6):492-505. PubMed ID: 20370700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols.
    Isemura M; Saeki K; Minami T; Hayakawa S; Kimura T; Shoji Y; Sazuka M
    Ann N Y Acad Sci; 1999 Jun; 878():629-31. PubMed ID: 10415792
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel inhibitors of fatty-acid synthase from green tea (Camellia sinensis Xihu Longjing) with high activity and a new reacting site.
    Zhang R; Xiao W; Wang X; Wu X; Tian W
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):1-7. PubMed ID: 15943584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea catechins and related polyphenols as anti-cancer agents.
    Isemura M; Saeki K; Kimura T; Hayakawa S; Minami T; Sazuka M
    Biofactors; 2000; 13(1-4):81-5. PubMed ID: 11237204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis).
    Aucamp J; Gaspar A; Hara Y; Apostolides Z
    Anticancer Res; 1997; 17(6D):4381-5. PubMed ID: 9494537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
    Thangapazham RL; Passi N; Maheshwari RK
    Cancer Biol Ther; 2007 Dec; 6(12):1938-43. PubMed ID: 18059161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea catechins as novel antitumor and antiangiogenic compounds.
    Demeule M; Michaud-Levesque J; Annabi B; Gingras D; Boivin D; Jodoin J; Lamy S; Bertrand Y; Béliveau R
    Curr Med Chem Anticancer Agents; 2002 Jul; 2(4):441-63. PubMed ID: 12678730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism-based in vitro anticancer drug screening approach for phenolic phytochemicals.
    Hsu S; Yu FX; Huang Q; Lewis J; Singh B; Dickinson D; Borke J; Sharawy M; Wataha J; Yamamoto T; Osaki T; Schuster G
    Assay Drug Dev Technol; 2003 Oct; 1(5):611-8. PubMed ID: 15090233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening.
    Peach ML; Tan N; Choyke SJ; Giubellino A; Athauda G; Burke TR; Nicklaus MC; Bottaro DP
    J Med Chem; 2009 Feb; 52(4):943-51. PubMed ID: 19199650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
    Chung JY; Huang C; Meng X; Dong Z; Yang CS
    Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of green tea polyphenols and the biological activities of those metabolites.
    Lambert JD; Sang S; Yang CS
    Mol Pharm; 2007; 4(6):819-25. PubMed ID: 17963356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.